Statements (55)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:Company
|
| gptkbp:acquisition |
Acquired by a private equity firm in 2021
|
| gptkbp:awards |
recognized for innovation in medical devices
|
| gptkbp:brand_recognition |
growing brand recognition in the industry
|
| gptkbp:ceo |
gptkb:Dr._John_B._Simpson
|
| gptkbp:clinical_trial |
conducted clinical trials for Ocelot
engaged in clinical research studies. |
| gptkbp:clinical_use |
used in various clinical applications
|
| gptkbp:community_engagement |
engages with local communities
|
| gptkbp:competitors |
competes with other medical device companies
|
| gptkbp:customer_base |
diverse customer base in healthcare
|
| gptkbp:employees |
51-200
|
| gptkbp:expansion |
plans for global expansion
|
| gptkbp:financial_performance |
reported financial performance metrics
|
| gptkbp:focus |
gptkb:peripheral_artery_disease
|
| gptkbp:founded |
gptkb:2014
|
| gptkbp:founder |
gptkb:Dr._John_B._Simpson
|
| gptkbp:headcount |
growing headcount since inception
|
| gptkbp:headquarters |
gptkb:Redwood_City,_California
|
| https://www.w3.org/2000/01/rdf-schema#label |
Avinger
|
| gptkbp:industry |
gptkb:medical_devices
|
| gptkbp:innovation |
focus on technology innovation in healthcare
|
| gptkbp:invention |
multiple patents in catheter technology
|
| gptkbp:investment |
various venture capital firms
secured investments for growth |
| gptkbp:market |
conducts market research for product development
|
| gptkbp:market_launch |
multiple product launches since founding
|
| gptkbp:market_position |
growing market presence in the US
|
| gptkbp:marketing_strategy |
developing market strategies for growth
|
| gptkbp:mission |
to improve patient outcomes
|
| gptkbp:partnership |
partnership with various hospitals
|
| gptkbp:partnerships |
collaborates with research institutions
|
| gptkbp:patient_education |
provides patient education resources
|
| gptkbp:product |
ongoing product development efforts
|
| gptkbp:products |
gptkb:Lumiere_Catheter
Ocelot Catheter |
| gptkbp:provides_guidance_on |
aligns with clinical guidelines for treatment
|
| gptkbp:regulatory_compliance |
FDA approved
ensures regulatory compliance in operations |
| gptkbp:research_and_development |
significant investment in R& D
|
| gptkbp:revenue |
reported revenue in 2020
|
| gptkbp:social_responsibility |
committed to social responsibility initiatives
|
| gptkbp:stock_symbol |
AVGR
|
| gptkbp:supply_chain |
manages a robust supply chain
|
| gptkbp:sustainability |
focus on sustainable practices
|
| gptkbp:target_market |
vascular surgeons
|
| gptkbp:team |
experienced leadership team
|
| gptkbp:technology |
image-guided therapy
|
| gptkbp:traded_on |
gptkb:NASDAQ
|
| gptkbp:treatment |
aims to improve clinical outcomes for patients
|
| gptkbp:user_feedback |
incorporates user feedback into product design
|
| gptkbp:vision |
to be a leader in vascular intervention
|
| gptkbp:website |
www.avinger.com
|
| gptkbp:bfsParent |
gptkb:St._Jude_Medical
|
| gptkbp:bfsLayer |
5
|